4,417
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Acute Effects of Acetaminophen on Renal Function and Urinary Excretion of Some Proteins and Enzymes in Patients with Kidney Disease

&
Pages 525-532 | Published online: 07 Jul 2009
 

Abstract

The acute effects of acetaminophen, a commonly used as analgesic drug, upon the urinary excretion of some proteins and enzymes as markers of kidney damage, was investigated. Patients with chronic glomerulo-nephritis (GN) and Balkan endemic nephropathy (BEN), having kidney vulnerable to toxic drugs, were enrolled in the study. Timed urine specimens were collected: before drug administration, and in 3-hour periods for 24 hours after an oral dose of 2 g of acetaminophen.

Urinary excretion of albumin before acetaminophen treatment was significantly higher in patients with GN and BEN than in healthy adults, however, β2-miicroglobulin excretion was increased in BEN patients only. Urinary excretion of creatinine markeldly increased immediately after acetaminophen ingestion. Urinary excretion of total protein and albumin was not changed after acetaminophen administration. However, acetaminophen treatment produced a significant increase in β2-miicroglobulin excretion in patient with BEN and GN, and in clinically healthy members of nephropathic families.

Excretion of aminopeptidase N (APN) activity before acetaminophen treatment was significantly higher in patients with GN, however, NAGA excretion was higher in both GN and BEN patients than in healthy controls. After acetaminophen administration urinary excretion of APN, di-peptidylpeptidase IV (DPP IV), γ-glutamyltranspeptidase (GGT) and N-acetyl-β-D-glucosaminidase (NAGA) did not increase significantly in any group studied.

This study has shown that urinary excretion of APN, DPP IV NAGA and GGT, as markers of kidney brush border and lysosomal damage, did not change after 2 g of acetaminophen taken orally. β2-miicroglobulin was a marker of acute acetaminophen nephrotoxicity in kidney disease patients and in clinically healthy adults from nephropathic families.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.